On the putative co‐transport of drugs by multidrug resistance proteins
Open Access
- 20 December 2005
- journal article
- review article
- Published by Wiley in FEBS Letters
- Vol. 580 (4), 1085-1093
- https://doi.org/10.1016/j.febslet.2005.12.039
Abstract
Experiments with multidrug resistance‐associated protein 1 (MRP1) showed 10‐years ago that transport of vincristine (VCR) by MRP1 could be stimulated by GSH, and transport of GSH by VCR. Since then many examples of stimulated transport have been reported for MRP1, 2, 3, 4 and 8. We discuss here three models to explain stimulated transport. We favour a model in which a large promiscuous binding site can bind more than one ligand, allowing cooperative/competitive interactions between ligands within the binding site. We conclude that there is no unambiguous proof for co‐transport of two different ligands by MRPs, but that cross‐stimulated transport can explain the published data.Keywords
This publication has 48 references indexed in Scilit:
- Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sitesAmerican Journal of Physiology-Renal Physiology, 2005
- Mrp2 is involved in benzylpenicillin-induced choleresisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- The potential impact of drug transporters on nucleoside-analog-based antiviral chemotherapyAntiviral Research, 2004
- Crystal Structures of QacR-Diamidine Complexes Reveal Additional Multidrug-binding Modes and a Novel Mechanism of Drug Charge NeutralizationJournal of Biological Chemistry, 2004
- cGMP and glutathione‐conjugate transport in human erythrocytesEuropean Journal of Biochemistry, 2003
- Differential Modulation of the Human Liver Conjugate Transporters MRP2 and MRP3 by Bile Acids and Organic AnionsJournal of Biological Chemistry, 2003
- Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4)Biochemical Journal, 2003
- Is There a Toxicological Advantage for Non-hyperbolic Kinetics in Cytochrome P450 Catalysis?Published by Elsevier ,2002
- Structure–Activity Studies of Verapamil Analogs That Modulate Transport of Leukotriene C4 and Reduced Glutathione by Multidrug Resistance Protein MRP1Biochemical and Biophysical Research Communications, 2000
- Enhancement of glucuronosyl etoposide transport by glutathione in multidrug resistance-associated protein-overexpressing cellsCancer Letters, 1998